Patents by Inventor David Applegate
David Applegate has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240086208Abstract: Systems and methods are provided for dynamically modeling and depicting overall emissions of the aviation industry and changes thereto when taking into account, for example, traffic growth and introduction of sustainability strategies, such as new and/or improved technologies, an increase in operational efficiency, and carbon offsets. Using the dynamic tool described herein, users can define scenarios on how to reduce emissions through the introduction of different sustainability strategies, both statically and over time, analyze the impact of those strategies on emissions, and understand the dependencies between select strategies.Type: ApplicationFiled: July 14, 2023Publication date: March 14, 2024Inventors: Jonas Schulze, Hilna Sahle, Anna-Lisa Mautes, Daniel Artic, Michael Gottscheck, Rahul Ashok, Neil Titchener, Nicholas Applegate, Hubert Wong, Nadine Akari, Lisa Liu, David Raymond, Brian Yutko
-
Publication number: 20230293344Abstract: Disclosed herein are drug delivery punctal implants and methods of using the implants for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The physical arrangement of drugs within the punctal plugs disclosed herein results, in several embodiments, in advantageous controlled delivery of one or more drugs to the eye of a patient.Type: ApplicationFiled: January 24, 2023Publication date: September 21, 2023Inventors: Thomas W. Burns, Douglas Daniel Crimaldi, David Applegate, Kenneth Martin Curry
-
Publication number: 20230090539Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allows for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.Type: ApplicationFiled: November 30, 2022Publication date: March 23, 2023Inventors: David S. Haffner, Kenneth M. Curry, Harold A. Heitzmann, David Applegate
-
Patent number: 11564833Abstract: Disclosed herein are drug delivery punctal implants and methods of using the implants for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The physical arrangement of drugs within the punctal plugs disclosed herein results, in several embodiments, in advantageous controlled delivery of one or more drugs to the eye of a patient.Type: GrantFiled: September 23, 2016Date of Patent: January 31, 2023Assignee: GLAUKOS CORPORATIONInventors: Thomas W. Burns, Douglas Daniel Crimaldi, David Applegate, Kenneth Martin Curry
-
Patent number: 11564569Abstract: An implantable intraocular physiological sensor for measuring intraocular pressure, glucose concentration in the aqueous humor, and other physiological characteristics. The implantable intraocular physiological sensor may be at least partially powered by a fuel cell, such as an electrochemical glucose fuel cell. The implantable intraocular physiological sensor may wirelessly transmit measurements to an external device. In addition, the implantable intraocular physiological sensor may incorporate aqueous drainage and/or drug delivery features.Type: GrantFiled: July 11, 2018Date of Patent: January 31, 2023Assignee: GLAUKOS CORPORATIONInventors: Thomas W. Burns, Harold A. Heitzmann, Kenneth Martin Curry, David S. Haffner, David Applegate, Bruce Nogales
-
Publication number: 20220330819Abstract: An implantable intraocular physiological sensor for measuring intraocular pressure, glucose concentration in the aqueous humor, and other physiological characteristics. The implantable intraocular physiological sensor may be at least partially powered by a fuel cell, such as an electrochemical glucose fuel cell. The implantable intraocular physiological sensor may wirelessly transmit measurements to an external device. In addition, the implantable intraocular physiological sensor may incorporate aqueous drainage and/or drug delivery features.Type: ApplicationFiled: June 20, 2022Publication date: October 20, 2022Inventors: Thomas W. Burns, Harold A. Heitzmann, Kenneth Martin Curry, David S. Haffner, David Applegate, Bruce Nogales
-
Patent number: 11363951Abstract: An implantable intraocular physiological sensor for measuring intraocular pressure, glucose concentration in the aqueous humor, and other physiological characteristics. The implantable intraocular physiological sensor may be at least partially powered by a fuel cell, such as an electrochemical glucose fuel cell. The implantable intraocular physiological sensor may wirelessly transmit measurements to an external device. In addition, the implantable intraocular physiological sensor may incorporate aqueous drainage and/or drug delivery features.Type: GrantFiled: September 12, 2012Date of Patent: June 21, 2022Assignee: GLAUKOS CORPORATIONInventors: Thomas W. Burns, Harold A. Heitzmann, Kenneth Martin Curry, David S. Haffner, David Applegate, Bruce Nogales
-
Publication number: 20210298948Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allows for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.Type: ApplicationFiled: March 31, 2021Publication date: September 30, 2021Inventors: David S. Haffner, Kenneth M. Curry, Harold A. Heitzmann, David Applegate
-
Publication number: 20210015662Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.Type: ApplicationFiled: October 1, 2020Publication date: January 21, 2021Inventors: David S. Haffner, Kenneth M. Curry, Harold A. Heitzmann, David Applegate
-
Patent number: 10813789Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.Type: GrantFiled: June 5, 2017Date of Patent: October 27, 2020Assignee: Dose Medical CorporationInventors: David S. Haffner, Kenneth M. Curry, Harold A. Heitzmann, David Applegate
-
Publication number: 20190083307Abstract: Disclosed herein are drug delivery punctal implants and methods of using the implants for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The physical arrangement of drugs within the punctal plugs disclosed herein results, in several embodiments, in advantageous controlled delivery of one or more drugs to the eye of a patient.Type: ApplicationFiled: September 23, 2016Publication date: March 21, 2019Inventors: Thomas W. BURNS, Bruce NOGALES, David APPLEGATE, Dave POWER
-
Publication number: 20190053704Abstract: An implantable intraocular physiological sensor for measuring intraocular pressure, glucose concentration in the aqueous humor, and other physiological characteristics. The implantable intraocular physiological sensor may be at least partially powered by a fuel cell, such as an electrochemical glucose fuel cell. The implantable intraocular physiological sensor may wirelessly transmit measurements to an external device. In addition, the implantable intraocular physiological sensor may incorporate aqueous drainage and/or drug delivery features.Type: ApplicationFiled: July 11, 2018Publication date: February 21, 2019Inventors: Thomas W. Burns, Harold A. Heitzmann, Kenneth Martin Curry, David S. Haffner, David Applegate, Bruce Nogales
-
Publication number: 20170281409Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.Type: ApplicationFiled: June 5, 2017Publication date: October 5, 2017Inventors: David S. Haffner, Kenneth M. Curry, Harold A. Heitzmann, David Applegate
-
Patent number: 9668915Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.Type: GrantFiled: November 22, 2011Date of Patent: June 6, 2017Assignee: DOSE MEDICAL CORPORATIONInventors: David Haffner, Ken Curry, Harold Heitzmann, David Applegate
-
Publication number: 20170135857Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allows for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.Type: ApplicationFiled: February 1, 2017Publication date: May 18, 2017Inventors: David S. Haffner, Kenneth M. Curry, Harold A. Heitzmann, David Applegate
-
Patent number: 8799967Abstract: A method includes receiving demand information for a first segment of a media content item and receiving demand information for a second segment of the media content item. The method includes assigning the first segment to a first set of distribution nodes of a media content distribution system based at least partially on the demand information for the first segment and based at least partially on a first cost function and assigning the second segment to a second set of distribution nodes of the media content distribution system based at least partially on the demand information for the second segment and based at least partially on a second cost function. The media content distribution system includes a plurality of distribution nodes and each distribution node is configured to provide media content items to at least some of a plurality of endpoints.Type: GrantFiled: October 25, 2011Date of Patent: August 5, 2014Assignee: AT&T Intellectual Property I, L.P.Inventors: David Applegate, Aaron Archer, Kyung-Wook Hwang, Vijay Gopalakrishnan, Seungjoon Lee, Kadangode K Ramakrishnan, Deborah F Swayne
-
Publication number: 20130289467Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.Type: ApplicationFiled: November 22, 2011Publication date: October 31, 2013Inventors: David Haffner, Ken Curry, Harold Heitzmann, David Applegate
-
Publication number: 20130104175Abstract: A method includes receiving demand information for a first segment of a media content item and receiving demand information for a second segment of the media content item. The method includes assigning the first segment to a first set of distribution nodes of a media content distribution system based at least partially on the demand information for the first segment and based at least partially on a first cost function and assigning the second segment to a second set of distribution nodes of the media content distribution system based at least partially on the demand information for the second segment and based at least partially on a second cost function. The media content distribution system includes a plurality of distribution nodes and each distribution node is configured to provide media content items to at least some of a plurality of endpoints.Type: ApplicationFiled: October 25, 2011Publication date: April 25, 2013Applicant: AT&T Intellectual Property I.L.P.Inventors: David Applegate, Aaron Archer, Kyung-Wook Hwang, Vijay Gopalakrishnan, Seungjoon Lee, Kadangode K. Ramakrishnan, Deborah F. Swayne
-
Publication number: 20130090534Abstract: An implantable intraocular physiological sensor for measuring intraocular pressure, glucose concentration in the aqueous humor, and other physiological characteristics. The implantable intraocular physiological sensor may be at least partially powered by a fuel cell, such as an electrochemical glucose fuel cell. The implantable intraocular physiological sensor may wirelessly transmit measurements to an external device. In addition, the implantable intraocular physiological sensor may incorporate aqueous drainage and/or drug delivery features.Type: ApplicationFiled: September 12, 2012Publication date: April 11, 2013Inventors: Thomas W. Burns, Harold A. Heitzmann, Kenneth Martin Curry, David S. Haffner, David Applegate, Bruce Nogales
-
Publication number: 20120078362Abstract: Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allows for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.Type: ApplicationFiled: May 18, 2010Publication date: March 29, 2012Applicant: DOSE MEDICAL CORPORATIONInventors: David Haffner, Ken Curry, Harold Heitzmann, David Applegate